Navigation Links
The GW Department of Biochemistry and Molecular Biology to host Nobel Laureate Dr. Ferid Murad
Date:9/27/2010

The George Washington University Medical Center's Department of Biochemistry & Molecular Biology welcomes the Nobel Laureate in Physiology or Medicine, Ferid Murad, M.D., Ph.D., as the inaugural speaker for The Nobel Laureate Distinguished Lecture Series. The series will showcase the achievements made within the scientific field in recent years. The inaugural lecture in this series will be co-sponsored by the GW Office of the Provost and the GW Office of the Vice President for Research.

In his lecture titled "NO Signaling: From Discovery to Drug Development," Dr. Murad will discuss his pioneering studies and breakthrough research on the mechanism of action of nitroglycerin, a drug used to reduce pain in cardiac ischemia among other uses. He will focus on the role of nitric oxide as a signaling molecule to relax smooth muscle and other new developments. Dr. Murad shared the Nobel Prize in Physiology or Medicine for this research in 1998 with Robert F. Furchgott, Ph.D., and Louis J. Ignarro, Ph.D.

Title: NO Signaling: From Discovery to Drug Development

When: Wednesday, September 29, 2010, 10:00 a.m.

Where: Funger Hall 103, 2201 G St. NW, Washington, D.C. 20037

Biography in brief

Born in Whiting, Indiana, Dr. Ferid Murad studied medicine and pharmacology simultaneously at Western Reserve University, receiving both his M.D. and Ph.D. in 1965. He was an intern and resident in internal medicine at Massachusetts General Hospital until 1967, and then worked until 1970 at the National Institutes of Health's National Heart and Lung Institute as a clinical associate and staff fellow.

He followed a series of academic, research, and administrative appointments, beginning at the University of Virginia, continuing on at Stanford University and Palo Alto Veterans Administration Medical Center, and more recently, at the University of Texas (1996-2010) where he serves as the Director of the Institute for Molecular Medicine, for the Houston School of Medicine.

Dr. Murad's work with nitric oxide began when he was in graduate school. He set out to learn how nitroglycerin, used for more than 100 years to treat angina, affected blood vessels. He found that nitroglycerin was effective because it prompted the release of nitric oxide, which relaxed smooth muscle cells. Prior to this, nitric oxide was best known as an air pollutant present in automobile exhaust fumes. The gas was known to be present in bacteria, but it was not thought to be important in higher order animals such as mammals. Based on this, Dr. Murad postulated that nitric oxide and other nitrogen-containing compounds (he coined the term nitro vasodilators to describe them) might be produced by one cell, travel through membranes, and then regulate the function other cells. At the time, this was an entirely new concept for signaling in biological systems. Nitric oxide is now known to play a key role in many biological functions including inflammation, blood flow regulation, cell growth, smooth muscle relaxation, and preserving memory.


'/>"/>

Contact: Anne Banner
mcmacb@gwumc.edu
202-994-2261
George Washington University Medical Center
Source:Eurekalert

Related biology news :

1. Jefferson Department of Surgery announces new pancreas tumor registry
2. UC Riverside rice geneticist receives high honor from US Department of Agriculture
3. New dummy design and development wins US Department of Defense award
4. Lockheed Martin Team Wins Role on Key Department of Defense Biometrics Contract Vehicle
5. Raytheon Chosen to Help Provide Department of Defense Biometrics Operations and Support Services
6. CSC Awarded Department of Defense Biometrics Contract
7. Story tips from the Departments of Energys Oak Ridge National Lab -- March 2009
8. Reforming defense department acquisition policy: UM expert
9. Story tips From the Department of Energys Oak Ridge National Laboratory -- May 2009
10. Story tips from the Department of Energys Oak Ridge National Laboratory, June 2009
11. Department of Energy supports carbon sequestration research, University of Miami receives $1.7 million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2016)... Das DOTM (Department ... hat ein 44 Millionen $-Projekt ... einschließlich Personalisierung, Registrierung und IT-Infrastruktur, an Decatur ... Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte internationale Anbieter ... aber Decatur wurde als konformste und innovativste ...
(Date:5/24/2016)... Ampronix facilitates superior patient care by providing unparalleled technology to leaders of ... the latest premium product recently added to the range of products distributed by Ampronix. ... ... ... Medical Display- Ampronix News ...
(Date:5/3/2016)... 2016  Neurotechnology, a provider of high-precision biometric ... Biometric Identification System (ABIS) , a complete system ... ABIS can process multiple complex biometric transactions with ... fingerprint, face or iris biometrics. It leverages the ... MegaMatcher Accelerator , which have been used ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... June 27, 2016 , ... ... will join the faculty of the University of North Carolina Kenan-Flagler Business ... strategy and entrepreneurship at UNC Kenan-Flagler, with a focus on the school’s international ...
(Date:6/27/2016)... June 27, 2016   Ginkgo Bioworks , a ... engineering, was today awarded as one of the ... the world,s most innovative companies. Ginkgo Bioworks is ... the real world in the nutrition, health and ... directly with customers including Fortune 500 companies to ...
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita Politecnica delle Marche in ... peritoneal or pleural mesothelioma. Their findings are the subject of a new article on ... biomarkers are signposts in the blood, lung fluid or tissue of mesothelioma patients that ...
Breaking Biology Technology: